Sun Medilab Private Limited
About Sun Medilab Private Limited
Data last updated:
Sun Medilab Private Limited was a private limited company based in New Delhi, Delhi, India. The company has been converted to a Limited Liability Partnership (LLP) and no longer exists as a company. For the latest details, refer to the successor LLP. It operated in the business and IT consulting segment of the business process outsourcing sector. It was incorporated on 11 December 2007.
The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U24100DL2007PTC171319. Its GSTIN is 07AALCS9930P1ZF (Delhi).
The company had an authorised share capital of ₹60 Lakh and a paid-up capital of ₹59 Lakh. It was led by directors Naresh Kumar Goel and Ramesh Kumar Goel.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office was at Plot No. 4 Upper Ground Floor Blk – A Pushpanjli Enclave Pitam Pura, New Delhi, Delhi, India – 110034.
As per the financials filed for FY 2025, the company reported a revenue of ₹23.05 Lakh, a decline of 3% compared to the previous year. For the same year it recorded a net profit of ₹15.09 Lakh (net margin 65.5%) and EBITDA of ₹20.12 Lakh (EBITDA margin 87.3%). Revenue has declined at a compounded annual rate (CAGR) of 14% over three years and 11% over five years.
Company details
Contact details
Sun Medilab Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No. 4 Upper Ground Floor Blk – A Pushpanjli Enclave Pitam Pura, New Delhi, Delhi, India – 110034
- IndustryBusiness Outsourcing, Business & IT Consulting
To see the full contact details of Sun Medilab Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Sun Medilab Private Limited
FY 2025 filings availableSun Medilab Private Limited reported revenue of ₹23.05 Lakh (down 3% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 11% over five years, including a 3% fall in the latest year. EBITDA rose 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹20.12 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹15.09 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 87.3% | ||||
| Net Profit Margin | 65.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sun Medilab Private Limited, buy the company report.
Board of directors of Sun Medilab Private Limited
Sun Medilab has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Naresh Kumar Goel | Director | 11 Dec 2007 | 18 Years 10 Months | As last reported |
| Ramesh Kumar Goel Also directs: Sun Medilab LLP, Cogni Pharmaceuticals LLP, Sentosa Geigy (India) Labs Limited and 3 more | Director | 01 Sep 2009 | 17 Years 1 Months | As last reported |
Peer comparison
Sun Medilab Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Caveat Pharma Private Limited | ₹23.16 Lakh (FY 2024) | 83.0% | Gurdaspur, Punjab, India | |||
| Joyce Healthcare Private Limited | ₹23.13 Lakh (FY 2017) | 62.0% | Thane, Maharashtra, India | |||
| Sun Medilab Private Limitedthis company | ₹23.05 Lakh (FY 2025) | ₹15.09 Lakh | 65.5% | -3.0% | New Delhi, Delhi, India | |
| Nucidem Lifesciences Private Limited | ₹23.02 Lakh (FY 2024) | -52.0% | New Delhi, Delhi, India |
To see the full peer comparison of Sun Medilab Private Limited, buy the company report.
Auditor
Sun Medilab Private Limited is audited by DHIRAJ AGGARWAL & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| DHIRAJ AGGARWAL & ASSOCIATES | FY 2023 | 036914N |
Shareholding
The shareholding of Sun Medilab Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Sun Medilab Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Sun Medilab Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sun Medilab Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sun Medilab has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AALCS9930P1ZF | Delhi | Active | 05 Apr 2019 |
To see the full GST registrations and return filing status of Sun Medilab Private Limited, buy the company report.
Recent activity
Sun Medilab Private Limited has 4 board changes on record since 2007: 2 appointments and 2 cessations. The latest: Mohit Goel ceased to be Additional Director on 17 Sep 2014.
Frequently asked questions
Sun Medilab has been "Converted to LLP" - the business changed its legal structure from a company to a Limited Liability Partnership. The original company no longer exists in its previous form. For the latest information, refer to the successor LLP entity registered with MCA.
Sun Medilab was a private limited company based in New Delhi, Delhi, India. The company worked in business and IT consulting, within the business outsourcing industry. It was incorporated on 11 December 2007 and is registered under CIN U24100DL2007PTC171319. For the latest details, refer to the successor LLP entity.
The CIN (Corporate Identification Number) of Sun Medilab is U24100DL2007PTC171319. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sun Medilab had 2 directors:
- Naresh Kumar Goel - Director
- Ramesh Kumar Goel - Director
Sun Medilab was incorporated on 11 December 2007. It is registered with the Registrar of Companies, Delhi.
The registered office of Sun Medilab is at Plot No. 4 Upper Ground Floor Blk – A Pushpanjli Enclave Pitam Pura, New Delhi, Delhi, India – 110034.
The latest financial statements of Sun Medilab on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Sun Medilab is 07AALCS9930P1ZF, registered in Delhi.
Sun Medilab operated in the business outsourcing industry, in the business and IT consulting segment.
The peers of Sun Medilab by revenue are Caveat Pharma Private Limited, Joyce Healthcare Private Limited, Nucidem Lifesciences Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (retail trading).
Mohit Goel ceased to be Additional Director on 17 Sep 2014. Vikas Goel ceased to be Director on 25 Dec 2013. Ramesh Kumar Goel was appointed as Director on 01 Sep 2009. Sun Medilab has 4 board changes on record in total.